Cutting-edge technology, featured by Harvard Business School, enables us to scale our unconflicted & comprehensive research across 10,000+ stocks, ETFs, and mutual funds. Learn more. Get a free trial. See Barron’s features of our research. This paper compares our analytics on a mega cap company to other major providers. The Appendix details exactly how we stack up.
A Micro-Bubble Brewing in the Home Goods Market
Micro-Bubbles: Winners & Losers
Featured Stock in January’s Safest Dividend Yields Model Portfolio
Comerica has grown revenue by 2% compounded annually and net operating profit after tax (NOPAT) by 20% compounded annually over the past ten years.
Outperforming Shorts That Could Fall Further
We first put Casper Sleep in the Danger Zone in February 2020 prior to its IPO just a few days later. At the time, we noted the firm’s slowing and profitless revenue growth, weak competitive position, exorbitant expenses, and overvalued stock price.
3 Outperformers With Room to Soar
Sector Ratings for ETFs & Mutual Funds: 1Q21
At the beginning of the first quarter of 2021, only the Consumer Non-cyclicals, Financials, and Basic Materials sectors earn an Attractive-or-better rating.
3 Long Ideas Poised to Outperform
All Cap Analysis: Free Cash Flow Yield Falls in 2020
All Cap Analysis: Only One Sector Has a Rising ROIC in 2020
All Cap Analysis: Net Income Understates Core Earnings in 2020
Within the NC 2000, only the Technology, Consumer Non-cyclicals, and Healthcare sectors saw a rise in Core Earnings since the end of 2019, same for the S&P 500.